- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Leukemia, Large Granular Lymphocytic
Medical specialists from France tagged as investigators in clinical trials studying Leukemia, Large Granular Lymphocytic
Total 61 results
-
Jérome REY, MDSeen in:
- Marseille, Hematology Unit - Institut Paoli-Calmettes
Trials:- NCT01976182 (Sub-Investigator)
Conditions: -
Joel Fleury, MDSeen in:
- Clermont-Ferrand, hematology Service - CHU Estaing
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Kamel LARIBI, MDSeen in:
- Le Mans cedex, Centre Hospitalier Du Mans
- Le Mans, CH Le Mans
- Le Mans, CH Le Mans/Service d'hématologie Oncologie
- Le Mans, Hematology Unit CH LE MANS
Trials:- NCT03503409 (Principal Investigator)
- NCT01976182 (Principal Investigator)
- NCT03744390 (Principal Investigator)
- NCT03223961 (Principal Investigator)
- NCT04827719 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Karine AUGEUL-MEUNIER, MDSeen in:
- Saint Priest en Jarez, Oncology Unit - Institut de cancérologie de la Loire
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Laurence SANHES, MDSeen in:
- Perpignan, Centre Hospitalier Joffre
- Perpignan, Centre Hospitalier Joffre-Perpignan
- Perpignan, Hematology Unit Hopital Saint Jean
Trials:- NCT00411905 (Principal Investigator)
- NCT01976182 (Principal Investigator)
- NCT03223961 (Principal Investigator)
-
Loic YSEBEART, MDSeen in:
- Toulouse, Hematology Unit CHU Toulouse
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Louis TERRIOU, MDSeen in:
- Lille, CHU de Lille - service d'Hématologie
- Lille, Hematology Unit CHRU Lille
- Nord, Lille, Hopital Cl Huriez
Trials:- NCT02817997 (Principal Investigator)
- NCT01976182 (Principal Investigator)
- NCT06444477 (Principal Investigator)
Conditions:- Castleman Disease;
- Castleman's Disease;
- Giant Lymph Node Hyperplasia;
- Angiofollicular Lymph Hyperplasia;
- Angiofollicular Lymph Node Hyperplasia;
- Angiofollicular Lymphoid Hyperplasia;
- GLNH;
- Hyperplasia, Giant Lymph Node;
- Lymph Node Hyperplasia, Giant;
- Large Granular Lymphocytes Leukemia;
- Neoplasms;
- Cancer;
- Immune Thrombocytopenia;
- Immune Thrombocytopenic Purpura
-
Lysiane Molina, MDSeen in:
- Grenoble, Hematology Unit CH Michalon
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Magda ALEXIS, MDSeen in:
- Orleans, Hematology Unit - CHR Orleans
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Malgorazata Truchand-Graczyk, MDSeen in:
- Angers, CHU Angers
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Marc MICHEL, MDSeen in:
- Creteil, CHU Henri Mondor Lymphoid Hemopathy Unit
Trials:- NCT01976182 (Sub-Investigator)
Conditions: -
Marie-Sarah DILHUYDY, MDSeen in:
- Pessac, Hematology Service- CH Haut Leveque
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Marion MALPHETTES, MDSeen in:
- Paris, Hematology Unit - Hopital Saint Louis
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Milena Kohn, MDSeen in:
- Versailles, Hôpital André Mignot Centre Hospitalier de Versailles
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Mohammed BELKAID, MDSeen in:
- Colmar, Hematology Service - Civils hospital
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Mourad TIAB, MDSeen in:
- La Roche Sur Yon, CHD Vendée
- La Roche sur Yon, Hematology Unit CHD Vendée
Trials:- NCT01976182 (Principal Investigator)
- NCT02066454 (Principal Investigator)
Conditions: -
Mustapha Ghomari, MDSeen in:
- Beauvais, hematology service - CH Beauvais
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Olivier Tournilhac, MDSeen in:
- Clermont-Ferrand, Chu Estaing
- Clermont-Ferrand, hematology Service - CHU Estaing
Trials:- NCT03439371 (Sub-Investigator)
- NCT01976182 (Sub-Investigator)
-
Pascal GODMER, MDSeen in:
- Vannes, CH Bretagne Atlantique
- Vannes, Intern Medecine Unit CHBA
Trials:- NCT01976182 (Principal Investigator)
- NCT03290456 (Principal Investigator)
-
Philippe CARASSOU, MDSeen in:
- Metz, Hematology Unit CH Notre Dame Bon Secours
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Pierre Feugier, MDSeen in:
- Nancy, CHRU Nancy
- Vandoeuvre les Nancy, CHU Brabois
- Vandoeuvre les Nancy, CHU de Brabois
- Vandoeuvre les Nancy, Hematology Unit Hopitaux de Brabois
- Vandœuvre-lès-Nancy, CHRU Nancy Brabois
- Vandœuvre-lès-Nancy, CHU de Nancy - Hôpital Brabois
Trials:- NCT01976182 (Principal Investigator)
- NCT03697512 (Principal Investigator)
- NCT04703686 (Principal Investigator)
- NCT04531046 (Principal Investigator)
- NCT04670029 (Principal Investigator)
- NCT05735834 (Principal Investigator)
Conditions:- Large Granular Lymphocytes Leukemia;
- Splenic Marginal Zone Lymphoma;
- Marginal Zone Lymphoma;
- Nodal Marginal Zone Lymphoma;
- Refractory Indolent Adult Non-Hodgkin Lymphoma;
- Refractory Mantle Cell Lymphoma;
- Diffuse Large B-Cell Lymphoma Refractory;
- Refractory Transformed B-cell Non-Hodgkin Lymphoma;
- Refractory Primary Mediastinal Large B-Cell Cell Lymphoma;
- B-cell Lymphoma Recurrent;
- B-Cell Lymphoma Refractory;
- Diffuse Large B Cell Lymphoma
-
Reda GARIDI, MDSeen in:
- Saint Quentin, CH Saint Quentin Oncohematology
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Regis Costello, MDSeen in:
- Marseille, Hematology Unit CHU La Conception
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Stéphane LEPETRE, MDSeen in:
- Rouen, Hematology Unit - CH Becquerel
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Sylvain CHOQUET, MDSeen in:
- Paris, Hematology Service - Hopital La Pitié Salpetrière
Trials:- NCT01976182 (Sub-Investigator)
Conditions: -
Thérèse Aurran-Schleinitz, MDSeen in:
- Marseille, Hematology Unit - Institut Paoli-Calmettes
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Thierry Lamy, PUPHSeen in:
- Rennes, Hematology Service - CHU of Rennes
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Véronique LEBLOND, MDSeen in:
- Paris, Hematology Service - Hopital La Pitié Salpetrière
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Vincent LAUNAY, MDSeen in:
- Saint-Brieuc, CH Yves Lefoll
Trials:- NCT01976182 (Principal Investigator)
Conditions: -
Wajed Abarah, MDSeen in:
- Meaux, Hematology Unit CH Meaux
Trials:- NCT01976182 (Principal Investigator)
Conditions:
Clinical Trials on Leukemia, Large Granular Lymphocytic
-
National Cancer Institute (NCI)CompletedT-Cell Large Granular Lymphocytic Leukemia | Leukemia, T-Cell Large Granular LymphocyticUnited States
-
Abcuro, Inc.RecruitingT-cell Large Granular Lymphocytic LeukemiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteEUSA Pharma, Inc.RecruitingLarge Granular Lymphocyte LeukemiaUnited States
-
John ReneauRecruitingT-Cell Large Granular Lymphocyte LeukemiaUnited States
-
German CLL Study GroupTerminatedT-Cell Large Granular Lymphocytic LeukemiaGermany
-
John ReneauBristol-Myers SquibbRecruitingT-Cell Large Granular Lymphocyte LeukemiaUnited States
-
National Cancer Institute (NCI)TerminatedT-cell Large Granular Lymphocyte Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage III Small Lymphocytic Lymphoma | Stage IV Small Lymphocytic Lymphoma | T-Cell Large Granular Lymphocyte Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage...United States, Denmark, Italy
-
Rennes University HospitalActive, not recruiting
-
National Cancer Institute (NCI)TerminatedLarge Granular Lymphocytic Leukemia | LGL LeukemiaUnited States